MindMed discovers, develops, and deploys psychedelic inspired medicines to improve health, promote wellness, and alleviate suffering. Today we are joined by MindMed founder and CEO JR Rahn. JR is a former Silicon Valley tech executive who realized that transformational solutions to mental illness and addiction might lie in psychedelic medicines. He spent 2 years researching and began personally investing in psychedelic research through his investment company.
